We've found
3,204
archived clinical trials in
Healthy Studies
We've found
3,204
archived clinical trials in
Healthy Studies
Characterization of Wild Blueberry Polyphenols Bioavailability and Kinetic Profile Over 24-hour Period
Updated: 12/31/1969
Characterization of Wild Blueberry Polyphenols Bioavailability and Kinetic Profile Over 24-hour Period
Status: Enrolling
Updated: 12/31/1969
Characterization of Wild Blueberry Polyphenols Bioavailability and Kinetic Profile Over 24-hour Period
Updated: 12/31/1969
Characterization of Wild Blueberry Polyphenols Bioavailability and Kinetic Profile Over 24-hour Period
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer
Updated: 12/31/1969
Impact of a Physical Activity Program on Biomarkers of Aging During Adjuvant or Neoadjuvant Chemotherapy for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer
Updated: 12/31/1969
Impact of a Physical Activity Program on Biomarkers of Aging During Adjuvant or Neoadjuvant Chemotherapy for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Food Effect and CYP1A2 Induction Study in Healthy Subjects
Updated: 12/31/1969
Hase I Open-Label Two-Part Study To Evaluate The Effect Of Food and Of CYP1A2 Induction On Pomalidomide (CC-4047) Pharmacokinetics in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Food Effect and CYP1A2 Induction Study in Healthy Subjects
Updated: 12/31/1969
Hase I Open-Label Two-Part Study To Evaluate The Effect Of Food and Of CYP1A2 Induction On Pomalidomide (CC-4047) Pharmacokinetics in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Effects of Coffee Beverage on Postprandial Inflammation and Oxidative Stress - A Pilot Study
Updated: 12/31/1969
Acute Effects of Coffee Beverage on Postprandial Inflammation and Oxidative Stress - A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Acute Effects of Coffee Beverage on Postprandial Inflammation and Oxidative Stress - A Pilot Study
Updated: 12/31/1969
Acute Effects of Coffee Beverage on Postprandial Inflammation and Oxidative Stress - A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study To Understand Safety And Plasma Concentrations Of PF-06669571 During And Following The Oral Administration Of Single And Multiple Doses Of PF-06669571 In Healthy Volunteers Under Fasted And Fed Conditions
Updated: 12/31/1969
A Phase 1, Double Blind, Sponsor Open, Placebo Controlled Combined Single And Multiple Ascending Dose Study To Investigate The Safety, Tolerability And Food Effect On Pharmacokinetics Of PF-06669571 Following Oral Doses In Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Study To Understand Safety And Plasma Concentrations Of PF-06669571 During And Following The Oral Administration Of Single And Multiple Doses Of PF-06669571 In Healthy Volunteers Under Fasted And Fed Conditions
Updated: 12/31/1969
A Phase 1, Double Blind, Sponsor Open, Placebo Controlled Combined Single And Multiple Ascending Dose Study To Investigate The Safety, Tolerability And Food Effect On Pharmacokinetics Of PF-06669571 Following Oral Doses In Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
Updated: 12/31/1969
Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
Status: Enrolling
Updated: 12/31/1969
Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
Updated: 12/31/1969
Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Dietary Methionine and Cysteine Restriction in Healthy Adults
Updated: 12/31/1969
Dietary Methionine and Cysteine Restriction in Healthy Adults
Status: Enrolling
Updated: 12/31/1969
Dietary Methionine and Cysteine Restriction in Healthy Adults
Updated: 12/31/1969
Dietary Methionine and Cysteine Restriction in Healthy Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Emotion Study -- A Neurofeedback Approach
Updated: 12/31/1969
Emotion Study -- Improving Neural Dysregulation in Advanced Age: A Neurofeedback Approach
Status: Enrolling
Updated: 12/31/1969
Emotion Study -- A Neurofeedback Approach
Updated: 12/31/1969
Emotion Study -- Improving Neural Dysregulation in Advanced Age: A Neurofeedback Approach
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Video to Promote HPV Vaccination
Updated: 12/31/1969
Educating Pre/Teens and Their Parents on the Importance of HPV Vaccination
Status: Enrolling
Updated: 12/31/1969
Video to Promote HPV Vaccination
Updated: 12/31/1969
Educating Pre/Teens and Their Parents on the Importance of HPV Vaccination
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Video to Promote HPV Vaccination
Updated: 12/31/1969
Educating Pre/Teens and Their Parents on the Importance of HPV Vaccination
Status: Enrolling
Updated: 12/31/1969
Video to Promote HPV Vaccination
Updated: 12/31/1969
Educating Pre/Teens and Their Parents on the Importance of HPV Vaccination
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Feasibility Study of Post-hospitalization Interventions to Improve Physical Function in Older Adults
Updated: 12/31/1969
Feasibility Study of Post-hospitalization Interventions to Improve Physical Function
Status: Enrolling
Updated: 12/31/1969
Feasibility Study of Post-hospitalization Interventions to Improve Physical Function in Older Adults
Updated: 12/31/1969
Feasibility Study of Post-hospitalization Interventions to Improve Physical Function
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Feasibility Study of Post-hospitalization Interventions to Improve Physical Function in Older Adults
Updated: 12/31/1969
Feasibility Study of Post-hospitalization Interventions to Improve Physical Function
Status: Enrolling
Updated: 12/31/1969
Feasibility Study of Post-hospitalization Interventions to Improve Physical Function in Older Adults
Updated: 12/31/1969
Feasibility Study of Post-hospitalization Interventions to Improve Physical Function
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Effects of Hydromorphone on Responses to Verbal Tasks
Updated: 12/31/1969
The Effects of Hydromorphone on Responses to Verbal Tasks
Status: Enrolling
Updated: 12/31/1969
The Effects of Hydromorphone on Responses to Verbal Tasks
Updated: 12/31/1969
The Effects of Hydromorphone on Responses to Verbal Tasks
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of LY2409021 in Healthy Participants
Updated: 12/31/1969
A Single Dose Pharmacokinetic Study of LY2409021 Tablet Administered in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Study of LY2409021 in Healthy Participants
Updated: 12/31/1969
A Single Dose Pharmacokinetic Study of LY2409021 Tablet Administered in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase I Study of an HIV Vaccine in Healthy, HIV Uninfected Adults
Updated: 12/31/1969
A Phase I Study of Modified Vaccinia Ankara With Mosaic HIV Inserts in Healthy, HIV-Uninfected Adults, Some of Whom Have Previously Received an Adenovirus Type 26 ENVA.01 Vaccine
Status: Enrolling
Updated: 12/31/1969
A Phase I Study of an HIV Vaccine in Healthy, HIV Uninfected Adults
Updated: 12/31/1969
A Phase I Study of Modified Vaccinia Ankara With Mosaic HIV Inserts in Healthy, HIV-Uninfected Adults, Some of Whom Have Previously Received an Adenovirus Type 26 ENVA.01 Vaccine
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Predictors of Lactogenesis II
Updated: 12/31/1969
Predictors and Moderators of Delayed Lactogenesis II and Duration of Breastfeeding
Status: Enrolling
Updated: 12/31/1969
Predictors of Lactogenesis II
Updated: 12/31/1969
Predictors and Moderators of Delayed Lactogenesis II and Duration of Breastfeeding
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Predictors of Lactogenesis II
Updated: 12/31/1969
Predictors and Moderators of Delayed Lactogenesis II and Duration of Breastfeeding
Status: Enrolling
Updated: 12/31/1969
Predictors of Lactogenesis II
Updated: 12/31/1969
Predictors and Moderators of Delayed Lactogenesis II and Duration of Breastfeeding
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Predictors of Lactogenesis II
Updated: 12/31/1969
Predictors and Moderators of Delayed Lactogenesis II and Duration of Breastfeeding
Status: Enrolling
Updated: 12/31/1969
Predictors of Lactogenesis II
Updated: 12/31/1969
Predictors and Moderators of Delayed Lactogenesis II and Duration of Breastfeeding
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study
Updated: 12/31/1969
Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study
Status: Enrolling
Updated: 12/31/1969
Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study
Updated: 12/31/1969
Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Evaluate Pharmacokinetics of Apremilast in Heatlhy Male Subjects
Updated: 12/31/1969
A Phase 1, Open-Label, Single Center Study to Evaluate the Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast (CC-10004) in Healthy Male Subjects
Status: Enrolling
Updated: 12/31/1969
Study to Evaluate Pharmacokinetics of Apremilast in Heatlhy Male Subjects
Updated: 12/31/1969
A Phase 1, Open-Label, Single Center Study to Evaluate the Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast (CC-10004) in Healthy Male Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of LY3079514 in Healthy Participants
Updated: 12/31/1969
A Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3079514 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Study of LY3079514 in Healthy Participants
Updated: 12/31/1969
A Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3079514 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of LY2835219 in Healthy Participants
Updated: 12/31/1969
Effects of CYP3A Induction by Rifampin on the Pharmacokinetics of LY2835219 and Its Metabolites in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Study of LY2835219 in Healthy Participants
Updated: 12/31/1969
Effects of CYP3A Induction by Rifampin on the Pharmacokinetics of LY2835219 and Its Metabolites in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults
Updated: 12/31/1969
Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults
Status: Enrolling
Updated: 12/31/1969
Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults
Updated: 12/31/1969
Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Bioequivalence of Duvelisib and Food Effect on Pharmacokinetics of IPI-145
Updated: 12/31/1969
A Phase 1, Open-label, 2-Part Study to Evaluate the Bioequivalence of the Duvelisib Marker-Image Formulation to the Duvelisib Clinical-Trial Formulation and to Assess the Effect of Food on the Pharmacokinetics of IP Duvelisib in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Bioequivalence of Duvelisib and Food Effect on Pharmacokinetics of IPI-145
Updated: 12/31/1969
A Phase 1, Open-label, 2-Part Study to Evaluate the Bioequivalence of the Duvelisib Marker-Image Formulation to the Duvelisib Clinical-Trial Formulation and to Assess the Effect of Food on the Pharmacokinetics of IP Duvelisib in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Family-Focused Intervention for Asian American Male Smokers
Updated: 12/31/1969
A Family-Focused Intervention for Asian American Male Smokers
Status: Enrolling
Updated: 12/31/1969
A Family-Focused Intervention for Asian American Male Smokers
Updated: 12/31/1969
A Family-Focused Intervention for Asian American Male Smokers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Family-Focused Intervention for Asian American Male Smokers
Updated: 12/31/1969
A Family-Focused Intervention for Asian American Male Smokers
Status: Enrolling
Updated: 12/31/1969
A Family-Focused Intervention for Asian American Male Smokers
Updated: 12/31/1969
A Family-Focused Intervention for Asian American Male Smokers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Family-Focused Intervention for Asian American Male Smokers
Updated: 12/31/1969
A Family-Focused Intervention for Asian American Male Smokers
Status: Enrolling
Updated: 12/31/1969
A Family-Focused Intervention for Asian American Male Smokers
Updated: 12/31/1969
A Family-Focused Intervention for Asian American Male Smokers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo- and Positive-Controlled, Multiple Dose, Four Way Crossover Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Subjects at Therapeutic and Supratherapeutic Dose Levels
Status: Enrolling
Updated: 12/31/1969
Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo- and Positive-Controlled, Multiple Dose, Four Way Crossover Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Subjects at Therapeutic and Supratherapeutic Dose Levels
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Metformin to Augment Strength Training Effective Response in Seniors (MASTERS)
Updated: 12/31/1969
Novel Actions of Metformin to Augment Resistance Training Adaptations in Older Adults
Status: Enrolling
Updated: 12/31/1969
Metformin to Augment Strength Training Effective Response in Seniors (MASTERS)
Updated: 12/31/1969
Novel Actions of Metformin to Augment Resistance Training Adaptations in Older Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Metformin to Augment Strength Training Effective Response in Seniors (MASTERS)
Updated: 12/31/1969
Novel Actions of Metformin to Augment Resistance Training Adaptations in Older Adults
Status: Enrolling
Updated: 12/31/1969
Metformin to Augment Strength Training Effective Response in Seniors (MASTERS)
Updated: 12/31/1969
Novel Actions of Metformin to Augment Resistance Training Adaptations in Older Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
Updated: 12/31/1969
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
Updated: 12/31/1969
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
Updated: 12/31/1969
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
Updated: 12/31/1969
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
Updated: 12/31/1969
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
Updated: 12/31/1969
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
Updated: 12/31/1969
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
Updated: 12/31/1969
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
Updated: 12/31/1969
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
Updated: 12/31/1969
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
Updated: 12/31/1969
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
Updated: 12/31/1969
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps
Updated: 12/31/1969
Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps
Status: Enrolling
Updated: 12/31/1969
Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps
Updated: 12/31/1969
Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps
Updated: 12/31/1969
Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps
Status: Enrolling
Updated: 12/31/1969
Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps
Updated: 12/31/1969
Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effects of Ferrous Sulfate on the Pharmacokinetics of AKB-6548
Updated: 12/31/1969
An Open-Label, Randomized, Single-Dose Study to Evaluate the Effects of 325 mg Ferrous Sulfate Tablet (65 mg Iron) on the Pharmacokinetics of 450 mg Dose of AKB-6548 in Healthy Male Volunteers.
Status: Enrolling
Updated: 12/31/1969
Effects of Ferrous Sulfate on the Pharmacokinetics of AKB-6548
Updated: 12/31/1969
An Open-Label, Randomized, Single-Dose Study to Evaluate the Effects of 325 mg Ferrous Sulfate Tablet (65 mg Iron) on the Pharmacokinetics of 450 mg Dose of AKB-6548 in Healthy Male Volunteers.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
N-acetylcysteine Effects on Tetrahydrocannabinol
Updated: 12/31/1969
Effect of N-acetylcysteine on the Acute Cognitive Effects of Delta-9-Tetrahydrocannabinol
Status: Enrolling
Updated: 12/31/1969
N-acetylcysteine Effects on Tetrahydrocannabinol
Updated: 12/31/1969
Effect of N-acetylcysteine on the Acute Cognitive Effects of Delta-9-Tetrahydrocannabinol
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pilot Study for Determination of Total Energy Expenditure and Fat Oxidation in Children
Updated: 12/31/1969
Pilot Study for Determination of Total Energy Expenditure and Fat Oxidation in Children.
Status: Enrolling
Updated: 12/31/1969
Pilot Study for Determination of Total Energy Expenditure and Fat Oxidation in Children
Updated: 12/31/1969
Pilot Study for Determination of Total Energy Expenditure and Fat Oxidation in Children.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assessing the Effectiveness and Safety of the ID-Cap System for Medication Monitoring and Adherence
Updated: 12/31/1969
A Phase II Randomized Trial to Assess the Effectiveness and Safety of the ID-Cap System for Medication Ingestion Monitoring and Enhancing Adherence
Status: Enrolling
Updated: 12/31/1969
Assessing the Effectiveness and Safety of the ID-Cap System for Medication Monitoring and Adherence
Updated: 12/31/1969
A Phase II Randomized Trial to Assess the Effectiveness and Safety of the ID-Cap System for Medication Ingestion Monitoring and Enhancing Adherence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Energetics and Function in Older Humans
Updated: 12/31/1969
Energetics and Function in Older Humans
Status: Enrolling
Updated: 12/31/1969
Energetics and Function in Older Humans
Updated: 12/31/1969
Energetics and Function in Older Humans
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety, Tolerability and Host Response to Lactobacillus Johnsonii
Updated: 12/31/1969
Safety, Tolerability and Host Response to Lactobacillus Johnsonii
Status: Enrolling
Updated: 12/31/1969
Safety, Tolerability and Host Response to Lactobacillus Johnsonii
Updated: 12/31/1969
Safety, Tolerability and Host Response to Lactobacillus Johnsonii
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic
Updated: 12/31/1969
Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic: A Prospective Controlled Study
Status: Enrolling
Updated: 12/31/1969
Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic
Updated: 12/31/1969
Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic: A Prospective Controlled Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
Updated: 12/31/1969
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
Status: Enrolling
Updated: 12/31/1969
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
Updated: 12/31/1969
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Evaluate the Effect of Increased Stomach pH on Evacetrapib in Healthy Participants
Updated: 12/31/1969
Evaluation of the Impact of Increased Gastric pH Following Omeprazole Administration on the Pharmacokinetics of Evacetrapib in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
A Study to Evaluate the Effect of Increased Stomach pH on Evacetrapib in Healthy Participants
Updated: 12/31/1969
Evaluation of the Impact of Increased Gastric pH Following Omeprazole Administration on the Pharmacokinetics of Evacetrapib in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Radiotracer [18F]Fluortriopride ([18F]FTP) by PET/CT
Updated: 12/31/1969
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluotriopride ([18F]FTP) by PET/CT
Status: Enrolling
Updated: 12/31/1969
Study of Radiotracer [18F]Fluortriopride ([18F]FTP) by PET/CT
Updated: 12/31/1969
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluotriopride ([18F]FTP) by PET/CT
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of LY2409021 Formulations in Healthy Participants
Updated: 12/31/1969
A Single Dose Pharmacokinetic Study of LY2409021 in Healthy Subjects to Bridge Formulations From Capsules to Commercial Tablets
Status: Enrolling
Updated: 12/31/1969
A Study of LY2409021 Formulations in Healthy Participants
Updated: 12/31/1969
A Single Dose Pharmacokinetic Study of LY2409021 in Healthy Subjects to Bridge Formulations From Capsules to Commercial Tablets
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment
Updated: 12/31/1969
A Single-Dose Pharmacokinetic Study of Abemaciclib (LY2835219) in Subjects With Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment
Updated: 12/31/1969
A Single-Dose Pharmacokinetic Study of Abemaciclib (LY2835219) in Subjects With Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials